Acoustic phase shift: Objective evidence for intralabyrinthine pressure disturbance in Menière’s disease provided by otoacoustic emissions - 08/03/12
, A. Montalban a, b, A. Bascoul a, b, L. Gilain a, b, P. Avan a, b
Corresponding author.Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 5 |
| Iconographies | 4 |
| Vidéos | 0 |
| Autres | 0 |
Summary |
Objectives |
Still today, Menière’s disease (MD) can be definitively diagnosed only on post-mortem findings of endolymphatic hydrops. Otoacoustic emission (OAE) phase has been shown to be highly sensitive to intracranial pressure. Preliminary analysis of OAEs in MD patients indicated high sensitivity to slight variations in intracranial pressure. The principal objective of the present study was to confirm this specific sensitivity of OAEs in MD.
Patients and methods |
In a prospective study of 32 consecutive cases of acute MD seen in consultation or hospital, 20 patients (23 ears) underwent acoustic phase-shift test: i.e., seated vs. supine OAE phase centered around 1kHz, with results compared to controls.
Results |
The acoustic phase-shift test was performed in 62.5% of acute patients (58.9% of affected ears). In the control group, the 95% confidence interval for phase shift was between –30° and +45°. Phase shift was significantly elevated, beyond the normal interval, in 18 of the MD patients: range, –80° to +145°. Sensitivity was 90%. Overall, in patients in whom transient evoked OAEs (TEOAEs) were present, positive predictive value was 100% and negative predictive value 92.3%.
Conclusions |
The acoustic phase-shift test proved useful and powerful in demonstrating pressure imbalance in acute Menière’s disease.
Le texte complet de cet article est disponible en PDF.Keywords : Menière’s disease, Hydrops, Vertigo, Intralabyrinthine pressure, Otoacoustic emissions
Plan
Vol 129 - N° 1
P. 17-21 - février 2012 Retour au numéro
Article précédent
- Salvage surgery after radiotherapy for oropharyngeal cancer. Treatment complications and oncological results
- C.-A. Righini, K. Nadour, C. Faure, R. Rtail, N. Morel, V. Beneyton, E. Reyt
- Ramsay Hunt syndrome
- R. Zainine, M. Sellami, A. Charfeddine, N. Beltaief, S. Sahtout, G. Besbes
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?